pyrroles and s 1743
pyrroles has been researched along with s 1743 in 24 studies
Research
Studies (24)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.17) | 29.6817 |
| 2010's | 17 (70.83) | 24.3611 |
| 2020's | 6 (25.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bokhart, GH; Jones, RJ; Sipe, BE | 1 |
| Araki, T; Komura, E; Mori, Y; Nishimura, A; Okamoto, H; Sakurai, Y; Shiramoto, M | 1 |
| Hunt, RH; Scarpignato, C | 1 |
| Inaba, T; Iwamuro, M; Okada, H; Toyokawa, T | 1 |
| Furuta, T; Hamaya, Y; Ichikawa, H; Iwaizumi, M; Kagami, T; Miyajima, H; Osawa, S; Sahara, S; Sugimoto, K; Sugimoto, M; Uotani, T; Yamade, M | 1 |
| Arai, M; Ishigami, H; Kasamatsu, S; Katsuno, T; Maruoka, D; Matsumura, T; Nakagawa, T; Okimoto, K; Saito, K; Taida, T; Yokosuka, O | 1 |
| Eguchi, T; Fujita, M; Fukuchi, T; Hashimura, H; Kanamori, A; Kano, C; Koizumi, A; Matsumoto, K; Momose, K; Okada, A; Shimoyama, K; Tsujimae, M; Yamashita, H | 1 |
| Izumi, M; Kato, S; Kato, Y; Masui, Y; Nakajima, A; Tanida, E; Tsuchiya, I | 1 |
| Furuta, T; Hamaya, Y; Iwaizumi, M; Kagami, T; Miyajima, H; Osawa, S; Sugimoto, K; Suzuki, T; Umemura, K; Uotani, T; Yamade, M | 1 |
| Czerniak, R; Nishihara, M | 1 |
| Furuta, T; Kagami, T | 1 |
| Jang, IJ; Ji, SC; Kim, HS; Lee, A; Lee, SH; Moon, SJ; Oh, J; Sunwoo, J; Yu, KS | 1 |
| Irie, K; Kaneko, H; Kondo, M; Maeda, S; Sasaki, T; Shibata, W; Sue, S | 1 |
| Eto, T; Ichida, T; Kusano, F; Sakai, Y; Ueyama, S | 1 |
| Fujie, S; Hasuda, K; Hattori, M; Hirano, M; Ito, K; Murao, T; Okuda, A; Sakurai, K; Suda, H; Takeichi, T; Tsuruta, K | 1 |
| Funakoshi, R; Furihata, K; Ito, K; Kudo, T; Kusuhara, H; Tomoda, Y | 1 |
| Choi, CW; Kang, DH; Kim, HW; Kim, SJ; Ko, J; Park, SB | 1 |
| Deguchi, H; Higuchi, K; Igarashi, A; Takeuchi, T; Uda, A; Yokoya, Y | 1 |
| Hongo, M; Hunt, RH; Lazarescu, A; Lottrup, C; Scarpignato, C; Stein, E; Wu, JCY | 1 |
| Fujino, T; Hiratsuka, T; Kato, Y; Miwa, W; Sato, K | 1 |
| Higuchi, K; Hirata, Y; Kakimoto, K; Kinoshita, N; Kojima, Y; Koshiba, R; Miyazaki, T; Nakamura, S; Ota, K; Takeuchi, T; Tanaka, Y; Tawa, H; Tsujimoto, H; Ueda, Y | 1 |
| Boinpally, R; Lu, K | 1 |
| Jang, IJ; Kim, B; Kim, S; Kim, Y; Lee, S; Park, SS; Song, GS; Yang, E; Yu, KS | 1 |
| Deguchi, H; Fernandez, J; Igarashi, A; Ishii, M; Kawai, T; Suzuki, M; Tsujita, K | 1 |
Reviews
1 review(s) available for pyrroles and s 1743
| Article | Year |
|---|---|
Pharmacologic treatment of GERD: Where we are now, and where are we going?
Topics: Cimetidine; Esomeprazole; Esophageal Mucosa; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2020 |
Trials
12 trial(s) available for pyrroles and s 1743
| Article | Year |
|---|---|
Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects--a randomised open-label cross-over study.
Topics: Adult; Cross-Over Studies; Esomeprazole; Gastric Acid; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Research Design; Sulfonamides | 2015 |
Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype.
Topics: Adult; Cross-Over Studies; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Administration Schedule; Esomeprazole; Female; Gastric Acid; Genotype; Humans; Hydrogen-Ion Concentration; Japan; Male; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2016 |
Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: Prospective randomized controlled trial.
Topics: Aged; Aged, 80 and over; Endoscopic Mucosal Resection; Esomeprazole; Female; Humans; Male; Postoperative Complications; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Stomach Neoplasms; Stomach Ulcer; Sulfonamides | 2017 |
Safety, tolerability, pharmacodynamics and pharmacokinetics of DWP14012, a novel potassium-competitive acid blocker, in healthy male subjects.
Topics: Administration, Oral; Adult; Amines; Anti-Ulcer Agents; Binding, Competitive; Dose-Response Relationship, Drug; Double-Blind Method; Esomeprazole; Healthy Volunteers; Humans; Male; Middle Aged; Placebos; Pyrroles; Sodium-Potassium-Exchanging ATPase; Young Adult | 2018 |
Randomized trial of vonoprazan-based versus proton-pump inhibitor-based third-line triple therapy with sitafloxacin for Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastritis; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Sulfonamides; Treatment Failure; Treatment Outcome | 2019 |
Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection.
Topics: Aged; Aged, 80 and over; Alanine; Anti-Ulcer Agents; Drug Therapy, Combination; Endoscopic Mucosal Resection; Esomeprazole; Female; Humans; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Quinolones; Severity of Illness Index; Stomach Neoplasms; Stomach Ulcer; Sulfonamides; Wound Healing | 2019 |
Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan.
Topics: Adult; Aged; Esomeprazole; Female; Gastroesophageal Reflux; Humans; Japan; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Remission Induction; Self Report; Sulfonamides; Time Factors; Treatment Outcome | 2019 |
Effects of proton pump inhibitors, esomeprazole and vonoprazan, on the disposition of proguanil, a CYP2C19 substrate, in healthy volunteers.
Topics: Adult; Area Under Curve; Atovaquone; Chromatography, Liquid; Cytochrome P-450 CYP2C19; Drug Combinations; Esomeprazole; Humans; Male; Proguanil; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Tandem Mass Spectrometry; Triazines; Young Adult | 2019 |
Dose-related healing of artificial ulcers after endoscopic submucosal dissection using esomeprazole: A randomized controlled study.
Topics: Endoscopic Mucosal Resection; Esomeprazole; Female; Humans; Male; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Republic of Korea; Stomach Neoplasms; Stomach Ulcer; Sulfonamides; Ulcer; Wound Healing | 2019 |
Effect of a proton-pump inhibitor on intestinal microbiota in patients taking low-dose aspirin.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Comorbidity; Dose-Response Relationship, Drug; Esomeprazole; Female; Gastrins; Gastrointestinal Hemorrhage; Gastrointestinal Microbiome; Hematocrit; Hemoglobins; Humans; Intestinal Mucosa; Lactobacillales; Male; Middle Aged; Polymorphism, Restriction Fragment Length; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2021 |
Evaluation of the Pharmacokinetic Interaction and Safety of Ubrogepant Coadministered With Esomeprazole Magnesium.
Topics: Adult; Esomeprazole; Female; Humans; Male; Migraine Disorders; Pyridines; Pyrroles | 2022 |
Night-time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole.
Topics: Benzene Derivatives; Cross-Over Studies; Cytochrome P-450 CYP2C19; Esomeprazole; Gastric Acid; Humans; Hydrogen-Ion Concentration; Imidazoles; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2022 |
Other Studies
11 other study(ies) available for pyrroles and s 1743
| Article | Year |
|---|---|
Rhabdomyolysis causing AV blockade due to possible atorvastatin, esomeprazole, and clarithromycin interaction.
Topics: Atorvastatin; Clarithromycin; Drug Interactions; Esomeprazole; Female; Heart Block; Heptanoic Acids; Humans; Middle Aged; Pyrroles; Rhabdomyolysis | 2003 |
Editorial: towards extended acid suppression--the search continues.
Topics: Esomeprazole; Humans; Male; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Sulfonamides | 2015 |
Letter: promising results of Helicobacter pylori eradication with vonoprazan-based triple therapy after failure of proton pump inhibitor-based triple therapy.
Topics: Esomeprazole; Humans; Male; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Sulfonamides | 2016 |
Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post-endoscopic submucosal dissection: A propensity score-matching analysis.
Topics: Aged; Endoscopic Mucosal Resection; Esomeprazole; Female; Follow-Up Studies; Gastroscopy; Humans; Male; Postoperative Complications; Propensity Score; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Stomach Neoplasms; Stomach Ulcer; Sulfonamides; Treatment Outcome | 2017 |
A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2016 |
Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype.
Topics: Adult; Asian People; Blood Platelets; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Esomeprazole; Female; Genotype; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrroles; Sulfonamides; Young Adult | 2018 |
CYP-Mediated Drug-Drug Interaction Is Not a Major Determinant of Attenuation of Antiplatelet Function of Clopidogrel by Vonoprazan.
Topics: Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Esomeprazole; Genotype; Prasugrel Hydrochloride; Pyrroles; Sulfonamides | 2018 |
Response to "CYP-Mediated Drug-Drug Interaction Is Not a Major Determinant of Attenuation of Antiplatelet Function of Clopidogrel by Vonoprazan".
Topics: Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Esomeprazole; Genotype; Prasugrel Hydrochloride; Pyrroles; Sulfonamides | 2018 |
Cost-utility analysis of a 'vonoprazan-first' strategy versus 'esomeprazole- or rabeprazole-first' strategy in GERD.
Topics: Computer Simulation; Cost-Benefit Analysis; Esomeprazole; Gastroesophageal Reflux; Humans; Japan; Markov Chains; Proton Pump Inhibitors; Pyrroles; Quality-Adjusted Life Years; Rabeprazole; Recurrence; Sulfonamides; Time Factors; Treatment Outcome | 2019 |
Marked reduction in the number of white globe appearance lesions in the noncancerous stomach after exchanging vonoprazan for esomeprazole treatment: a follow-up case report.
Topics: Aged; Esomeprazole; Female; Follow-Up Studies; Humans; Proton Pump Inhibitors; Pyrroles; Stomach; Sulfonamides | 2021 |
Cost-Effectiveness of Vonoprazan Compared With Proton Pump Inhibitors in Patients Taking Low-Dose Aspirin for Secondary Prevention of Cardiovascular Events in Japan.
Topics: Aged; Aspirin; Cardiovascular Diseases; Cost-Benefit Analysis; Esomeprazole; Gastrointestinal Hemorrhage; Humans; Japan; Lansoprazole; Proton Pump Inhibitors; Pyrroles; Secondary Prevention | 2023 |